Overview
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development.
Bringing disciplines together in a cross-functional environment, this team includes antibody engineers, molecular biologists, and cell biologists who are driving innovative solutions to bring new treatments to patients faster.
Learn more about the work being done at AbCellera’s locations in Boston, USA; Vancouver, Canada; Sydney, Australia; and Cambridge, UK by visiting abcellera.com